Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7116062 | 7678242 | I | 7116062-7 | 20101102 | 20101112 | 20101122 | EXP | JP-BAXTER-2010BH028443 | BAXTER | 60 | YR | M | Y | 20101122 | MD | JAPAN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7116062 | 1015163049 | PS | CYCLOPHOSPHAMIDE | 1 | INTRAVENOUS DRIP | UNKNOWN | |||||
| 7116062 | 1015163050 | C | AMLODIPINE BESYLATE | 1 | ORAL | ||||||
| 7116062 | 1015163051 | C | TAKEPRON | 2 | ORAL | ||||||
| 7116062 | 1015163052 | C | DIFLUCAN | 1 | ORAL | ||||||
| 7116062 | 1015163053 | C | ZOMETA | 1 | INTRAVENOUS DRIP | ||||||
| 7116062 | 1015163054 | C | BENAMBAX | 2 | UNKNOWN |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 7116062 | 1015163049 | MULTIPLE MYELOMA |
| 7116062 | 1015163050 | HYPERTENSION |
| 7116062 | 1015163051 | PROPHYLAXIS |
| 7116062 | 1015163052 | PROPHYLAXIS |
| 7116062 | 1015163053 | MULTIPLE MYELOMA |
| 7116062 | 1015163054 | MULTIPLE MYELOMA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 7116062 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 7116062 | HYPERURICAEMIA |
| 7116062 | OEDEMA |
| 7116062 | PROTEINURIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 7116062 | 1015163049 | 20101014 | 20101015 | ||
| 7116062 | 1015163050 | 20101110 |